Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 26, 2019

SELL
$5.16 - $6.85 $603,204 - $800,765
-116,900 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.89 - $7.16 $70,416 - $103,104
14,400 Added 14.05%
116,900 $593,000
Q3 2018

Oct 29, 2018

SELL
$6.89 - $7.78 $50,297 - $56,794
-7,300 Reduced 6.65%
102,500 $739,000
Q2 2018

Jul 26, 2018

BUY
$5.19 - $7.25 $569,862 - $796,050
109,800 New
109,800 $732,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.